OptimizeRx (OPRX) Stock: Buy, Sell, or Hold?
OPRX - OptimizeRx Corporation Common Stock
$8.50
-0.35 (-3.95%)
âŧ
5d:
+2.66%
30d:
+11.99%
90d:
+30.57%
WAIT
LOW Confidence
Analysis Updated: Oct 16, 2026 12:00 AM ET
Earnings: Nov 05, 2026
16d
Get Alerted When OPRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OPRX is fairly priced but lacks strong directional signals. At -0.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OPRX is fairly priced but lacks strong directional signals. At -0.6% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$14.91
Based on 11.6% avg growth
INTRINSIC VALUE TODAY
$9.26
8.2% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 8.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPRX is currently trading at $8.50, which is considered slightly high relative to its 30-day fair value range of $7.51 to $8.53. The stock's valuation (Forward PE: 8.1) is in line with its historical norms (8.3). Remarkably, the market is currently pricing in an annual earnings decline of 0.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, OPRX is in a strong uptrend. Immediate support is located at $8.11, while resistance sits at $9.18. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.60 (+48.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPRX is in a strong uptrend. Immediate support is located at $8.11, while resistance sits at $9.18. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (27th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $12.60 (+48.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$7.51 -
$8.53
Company Quality Score
50/100
(HOLD)
Options IV Signal
27th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
68.1%
Protect Your Profits
Holding OPRX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Options cheap (IV 27th percentile)
- NEUTRAL: Mixed technical signals (46/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 48.2% below Wall St target ($12.60)
- WARNING: Composite score 50/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$7.51 -
$8.53
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
Âą$0.93
(10.9%)
Support & Resistance Levels
Support Level
$8.11
Resistance Level
$9.18
Current Trend
Strong Uptrend
Technical data as of
Oct 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
8.14
Wall Street Target
$12.60
(+48.2%)
Revenue Growth (YoY)
-29.8%
Earnings Growth (YoY)
-66.8%
Profit Margin
4.7%
Valuation Discount vs History
-0.6% cheaper
PE vs Historical
8.1 vs 8.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.6%
(market-implied from PE analysis)
1-Year Target
$8.45
(-1%)
2-Year Target
$8.40
(-1%)
3-Year Target
$8.35
(-2%)
3-Yr Target (if PE normalizes)
(PE: 8â8)
$8.51
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 19.2%)
$35.10
(+313%)
Base:
(SPY PE: 8.1, Growth: 19.2%)
$14.39
(+69%)
Bear:
(PE: 6.9, Growth: 19.2%)
$12.23
(+44%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (37x PE), but valuation improves significantly next year (8x PE) as earnings recover.
Trailing PE: 36.88 | Current EPS (TTM): $0.24
Bull Case
$19.47
(+129%)
Analyst growth 100.0%, PE expands to 40.6
Base Case
$17.70
(+108%)
Market implied 100.0%, PE stable at 36.9
Bear Case
$6.02
(-29%)
Severe decline -20.0%, PE contracts to 31.3
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 8.1 to 8.3
Stabilization Target:
$8.67
(+1.9%)
PE Expansion Potential:
+1.9%
Share & Embed Analysis
Last updated: October 18, 2026 11:03 PM ET
Data refreshes hourly during market hours. Next update: 12:03 AM
Data refreshes hourly during market hours. Next update: 12:03 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
29 analysts |
$297 | 34 SELL |
|
BTSG
BrightSpring Health ServâĻ |
STRONG BUY
18 analysts |
$79 | 51 HOLD |
|
WAY
Waystar Holding Corp. CoâĻ |
STRONG BUY
23 analysts |
$34 | 29 SELL |
|
HQY
HealthEquity Inc |
STRONG BUY
15 analysts |
$119 | 56 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$90 | 45 HOLD |
Advanced OPRX Option Strategies
Professional options setups generated by AI based on today's OPRX price and gamma walls.
